Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis
Autor: | Genovese, Mark C *, Smolen, Josef S, Takeuchi, Tsutomu, Burmester, Gerd, Brinker, Dennis, Rooney, Terence P, Zhong, Jinglin, Daojun, Mo, Saifan, Chadi, Cardoso, Anabela, Issa, Maher, Wu, Wen-Shuo, Winthrop, Kevin L |
---|---|
Zdroj: | In The Lancet Rheumatology June 2020 2(6):e347-e357 |
Databáze: | ScienceDirect |
Externí odkaz: |